Achilles Therapeutics' £13.2M Launch

News   Oct 06, 2016

 
Achilles Therapeutics' £13.2M Launch
 
 
 
 

RELATED ARTICLES

Why Combining Two Checkpoint Inhibitors is More Effective Than Using Them in Isolation

News

A team at the MD Anderson Cancer center team has found that checkpoint inhibitors fire up different types of T cells to attack tumors

READ MORE

Brain-in-a-Dish Models Neuroinflammation

News

A human stem cell-based model of a rare, but devastating, inherited neurological autoimmune condition called Aicardi-Goutieres Syndrome has been created.

READ MORE

Cell ‘Checkpoint’ that Stops Allergic Diseases Identified

News

Scientists from Trinity College Dublin have made a significant breakthrough in understanding the regulation of immune cells that play a pivotal role in allergic diseases such as asthma and eczema.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE